Attached files

file filename
8-K/A - FORM 8-K/A - SOLENO THERAPEUTICS INCd32615d8ka.htm
EX-99.1 - EX-99.1 - SOLENO THERAPEUTICS INCd32615dex991.htm
EX-99.2 - EX-99.2 - SOLENO THERAPEUTICS INCd32615dex992.htm

Exhibit 99.3

Capnia, Inc.

Unaudited Pro Forma Condensed Combined Financial Statements

On September 2, 2015, Capnia, Inc. (the “Company”) established NeoForce Acquisition, Inc., or NFI, a wholly owned subsidiary incorporated in the State of Delaware. On September 8, 2015, NFI acquired substantially all of the assets of an unrelated privately held company NeoForce Group, Inc., or NeoForce Group, in exchange for an upfront cash payment of $1.0 million and royalties on future sales. Included in the assets acquired were intellectual property rights, including the patents, that NeoForce Innovations, LLC, an affiliate of NeoForce Group, assigned, transferred and conveyed to NeoForce Group on September 4, 2015. The following unaudited pro forma condensed combined balance sheet as of June 30, 2015 is based on the historical consolidated financial statements of the Company and the impact that the addition of the assets on the Company’s financial position. The unaudited pro forma condensed combined statements of income present the combined results of the Company’s operations with NeoForce Group as if the acquisition of the assets had occurred at the beginning of each of the periods presented and include adjustments that are directly attributable to the acquisition, are expected to have a continuing impact on the combined results, and are factually supportable. The unaudited pro forma condensed combined financial statements are not necessarily indicative of what our financial position or results of operations actually would have been had we completed the acquisition of the assets at the dates indicated. In addition, the unaudited pro forma condensed combined financial information does not purport to project the future financial position or operating results of the combined company.

These Unaudited Pro Forma Condensed Financial Statements should be read in conjunction with the:

 

    Separate historical financial statements of the Company as of and for the year ended December 31, 2014 included in the Company’s Annual Report on Form 10-K; and

 

    Separate historical financial statements of the Company as of and for the six months ended June 30, 2015 included in the Company’s Quarterly Report on Form 10-Q for the six month period ended June 30, 2015.

The transaction has been accounted for as a business combination under the acquisition method of accounting. Accordingly, the tangible assets and identifiable intangible assets acquired have been recorded at fair value, with the remaining purchase price recorded as goodwill, based on a valuation performed by an independent valuation firm. The fair value of current assets approximated their book value. The fair value of acquired assets and liabilities were determined using several significant unobservable inputs for projected cash flows and a discount rate. The Company’s historical consolidated financial information has been adjusted to give effect to the impact of the consideration paid in connection with the acquisition. The amounts allocated to the assets in the Unaudited Pro Forma Condensed Combined Balance Sheet are based on an independent valuation of the fair value of the assets as of September 8, 2015. The Company did not assume any liabilities that would be recorded on the Unaudited Pro Forma Condensed Combined Balance Sheet.


Capnia, Inc.

Unaudited Pro Forma Condensed Consolidated Statements of Operations

Year Ended December 31, 2014

(In thousands, except share and per share data)

(unaudited)

 

                 Proforma        
     Capnia     NeoForce     Adjustments
(Note 3)
    Pro Forma
Combined
 

Revenue

   $ —        $ 988      $ —        $ 988   

Cost of product revenue

     —          485        —          485   
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     —          503        —          503   
  

 

 

   

 

 

   

 

 

   

 

 

 

Expenses

        

Research and development

     2,242        —          —          2,242   

Sales and marketing

     252        —          —          252   

General and administrative

     2,665        500        53 (a)      3,218   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses

     5,159        500        53        5,712   

Operating income (loss)

     (5,159     3        (53     (5,209

Interest expense

     (4,131     (19     —          (4,150

Other income (expense)

     (3,949     —          —          (3,949
  

 

 

   

 

 

   

 

 

   

 

 

 

Other income (expense), net

     (8,080     (19     —          (8,099
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

   $ (13,239   $ (16   $ (53   $ (13,308
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss per common share:

        

Basic and diluted

   $ (10.42     —          —        $ (10.48
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted-average common shares outstanding used to calculate net loss per common share:

        

Basic and diluted

     1,270,033        —          —          1,270,033   
  

 

 

   

 

 

   

 

 

   

 

 

 

See accompanying notes to unaudited pro forma combined financial statements


Capnia, Inc.

Unaudited Pro Forma Condensed Consolidated Statements of Operations

Six Months Ended June 30, 2015

(In thousands, except share and per share data)

(unaudited)

 

                 Proforma        
     Capnia     NeoForce     Adjustments
(Note 3)
    Pro Forma
Combined
 

Government grant revenue

   $ 65      $ —        $ —        $ 65   

Product revenue

     54        391        —          445   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total revenue

     119        391        —          510   

Cost of product revenue

     40        185        —          225   
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     79        206        —          285   
  

 

 

   

 

 

   

 

 

   

 

 

 

Expenses

        

Research and development

     2,059        —          —          2,059   

Sales and marketing

     772        —          —          772   

General and administrative

     2,718        244        27 (a)      2,989   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses

     5,549        244        27        5,820   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating loss

     (5,470     (38     (27     (5,535
  

 

 

   

 

 

   

 

 

   

 

 

 

Interest and expense

     (1     (9     —          (10

Change in fair value of warrants liabilities

     (1,249     —          —          (1,249

Inducement charge for Series C warrants

     (3,050     —          —          (3,050
  

 

 

   

 

 

   

 

 

   

 

 

 

Other income (expense), net

     (4,300     (9     —          (4,309
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

   $ (9,770   $ (47   $ (27   $ (9,844
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss per common share:

        

Basic and diluted

   $ (1.35     —          —        $ (1.36
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted-average common shares outstanding used to calculate net loss per common share:

        

Basic and diluted

     7,243,164        —          —          7,243,164   
  

 

 

   

 

 

   

 

 

   

 

 

 

See accompanying notes to unaudited pro forma condensed combined financial statements


Capnia, Inc.

Unaudited Pro Forma Condensed Combined Balance Sheet

As of June 30, 2015

(In thousands, except share data)

(unaudited)

 

           Proforma        
     Capnia     Adjustments
(Note 3)
    Pro Forma
Combined
 

Assets

      

Current assets

      

Cash and cash equivalents

   $ 7,530      $ (1,000 )(b)    $ 6,530   

Accounts receivable

     12        —          12   

Restricted cash

     35        —          35   

Inventory

     277        —          277   

Prepaid expenses and other current assets

     311        —          311   
  

 

 

   

 

 

   

 

 

 

Total current assets

     8,165        (1,000     7,165   

Long-term assets

      

Property and equipment, net

     43        39 (b)      82   

Other assets

       —          0   

Goodwill

     0        718 (b)      718   

Other intangible assets, net

     562        316 (b)(c)      878   
  

 

 

   

 

 

   

 

 

 

Total assets

   $ 8,770      $ 73      $ 8,843   
  

 

 

   

 

 

   

 

 

 

Liabilities and stockholders’ deficit

      

Current liabilities

      

Accounts payable

   $ 989      $ —        $ 989   

Accrued compensation and other current liabilities

     1,223        42 (d)      1,265   

Common Stock Issuable

     112        —          112   

Series B warrant liability

     11,025        —          11,025   

Line of credit and accrued interest

     —          —          0   
  

 

 

   

 

 

   

 

 

 

Total current liabilities

     13,349        42        13,391   

Long-term liabilities

      

Series A warrant liability

     2,159        —          2,159   

Series B warrant liability

     —          —          0   

Series C warrant liability

     894        —          894   

Other liabilities

     —          111 (d)      111   
  

 

 

   

 

 

   

 

 

 

Total long-term liabilities

     3,053        111        3,164   
  

 

 

   

 

 

   

 

 

 

Total liabilities

     16,402        153        16,555   
  

 

 

   

 

 

   

 

 

 

Stockholders’ deficit

      

Common stock, $0.001 par value, 100,000,000 shares authorized at June 30, 2015; 7,595,175 shares issued and outstanding at June 30, 2015

     8        —          8   

Additional paid-in-capital

     72,469        —          72,469   

Accumulated deficit

     (80,109     (80 )(c)      (80,189
  

 

 

   

 

 

   

 

 

 

Total stockholders’ deficit

     (7,632     (80     (7,712
  

 

 

   

 

 

   

 

 

 

Total liabilities and stockholders’ deficit

   $ 8,770      $ 73      $ 8,843   
  

 

 

   

 

 

   

 

 

 

See accompanying notes to unaudited pro forma condensed combined financial statements


Notes to Unaudited Pro Forma Condensed Combined Financial Statements

Note 1: Description of transaction and basis of presentation

On September 2, 2015, Capnia, Inc. (the “Company”) established NeoForce Acquisition, Inc., or NFI, a wholly owned subsidiary incorporated in the State of Delaware. On September 8, 2015, NFI acquired substantially all of the assets of an unrelated privately held company NeoForce Group, Inc., or NeoForce Group, in exchange for an upfront cash payment of $1.0 million and royalties on future sales.

Note 2: Purchase price

For the purposes of this pro forma analysis, the purchase price has been allocated to the tangible assets and identifiable intangible assets acquired based on their respective fair values, with the remaining purchase price recorded as goodwill.

The aggregate purchase price consideration was as follows (in thousands):

 

Cash consideration

   $ 1,000   

Fair value of contingent consideration

     153   
  

 

 

 

Total purchase price consideration

   $ 1,153   

The agreement to pay the annual royalty resulted in the recognition of a contingent consideration, which is recognized at the inception of the transaction, and subsequent changes to the estimated amounts of contingent consideration to be paid will be recognized as charges or credits in the statement of operations. The fair value of the contingent consideration is based on preliminary cash flow projections, growth in expected product sales and other assumptions. Based on the assumptions, the fair value of the royalty was determined to be $153,000 at September 8, 2015, the date of acquisition. The fair value of the royalty was determined by applying the income approach, using several significant unobservable inputs for projected cash flows and a discount rate of 20% commensurate with the Company’s cost of capital and expectation of the revenue growth for products at their life cycle stage.

The fair values of assets acquired at the transaction date are summarized below:

 

Net tangible assets acquired

   $ 39   

Customer contracts

     260   

Patents

     136   

Goodwill

     718   
  

 

 

 

Net Assets Acquired

   $ 1,153   


Note 3: Pro Forma Adjustments

Pro forma adjustments are necessary to reflect the estimated purchase price and the fair valuation of acquired assets. The pro forma adjustments included in the unaudited pro forma condensed combined financial statements are as follows:

 

  (a) The adjustment for the amortization of customer contracts over a 5 year life and patents over a 10 year life, assuming that the acquisition of the assets occurred as of January 1, 2014.

 

  (b) The adjustment for the cash purchase price of $1.0 million and to record the estimated fair value of the assets acquired. (See Note 2).

 

  (c) The adjustment to reduce the acquired intangible assets (patents and customer contracts) of $396,000 by the accumulated amortization of $80,000 from January 1, 2014 through June 30, 2015. Increase in accumulated deficit by the accumulated amortization of $80,000.

 

  (d) The adjustment to record the current royalty payable under the purchase agreement, which provides for an annual royalty of 3% on sales up to $1 million. The reclassification to current liability the amount of contingent consideration of $30,000 and $12,000 due for year ended December 31, 2014 and the six months ended June 2015, respectively.